Adenosine modifies colchicine-uptake into tissues from the mammalian brain

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Colchicine is a known microtubule-disrupting agent.
• Understanding colchicine's interaction with cerebral tissues is crucial for neuropharmacology.
• The role of endogenous substances in modulating drug uptake requires investigation.

Purpose of the Study:

• To investigate the uptake and binding of colchicine in isolated cerebral tissues.
• To explore the influence of adenosine and related compounds on colchicine's cellular disposition.
• To elucidate potential mechanisms of colchicine entry and its interaction with cellular components.

Main Methods:

• Incubation of isolated cerebral tissues in glucose-salt solutions with colchicine.
• Superfusion with colchicine-free solutions to assess retention.
• Fractionation of cytosolic and particulate components to determine colchicine binding.
• Assessment of the effects of adenosine, 2-chloroadenosine, cyclic AMP, theophylline, adenosine deaminase, and dipyridamole on colchicine uptake and binding.

Main Results:

• Isolated cerebral tissues effectively take up and retain colchicine.
• The majority of intracellular colchicine remains unbound after incubation.
• Uptake and binding of colchicine are significantly reduced by adenosine and depolarization.
• Cyclic AMP and 2-chloroadenosine also decrease colchicine uptake, while theophylline and adenosine deaminase increase it.

Conclusions:

• Adenosine and neuronal activity modulate colchicine uptake and binding in cerebral tissues.
• Adenylate cyclase complexes, potentially associated with tubulin, may mediate colchicine entry.
• Environmental and cellular signals can influence colchicine's interaction with brain preparations, impacting its toxicity.